Wen-Hui Wang Selected Research

Hypokalemia

1/2021	Deletion of renal Nedd4-2 abolishes the effect of high sodium intake (HS) on Kir4.1, ENaC, and NCC and causes hypokalemia during high HS.
1/2020	Renal Tubule Nedd4-2 Deficiency Stimulates Kir4.1/Kir5.1 and Thiazide-Sensitive NaCl Cotransporter in Distal Convoluted Tubule.
1/2019	Kir4.1/Kir5.1 in the DCT plays a role in the regulation of renal K+ excretion.
1/2018	Potassium intake modulates the thiazide-sensitive sodium-chloride cotransporter (NCC) activity via the Kir4.1 potassium channel.
6/2017	Potassium Sensing by Renal Distal Tubules Requires Kir4.1.
1/2016	The expression, regulation, and function of Kir4.1 (Kcnj10) in the mammalian kidney.
8/2014	KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1).
6/2010	Decrease in dietary K intake stimulates the generation of superoxide anions in the kidney and inhibits K secretory channels in the CCD.
5/2009	Inhibition of angiotensin type 1 receptor impairs renal ability of K conservation in response to K restriction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Hui Wang Research Topics

Disease

12	Hypertension (High Blood Pressure) 01/2022 - 06/2006
9	Hypokalemia 01/2021 - 05/2009
8	Neoplasms (Cancer) 01/2022 - 05/2014
4	Alkalosis 01/2019 - 08/2014
3	Infections 04/2022 - 01/2019
3	Hyperkalemia 01/2022 - 01/2017
3	COVID-19 10/2021 - 12/2020
2	Body Weight (Weight, Body) 01/2022 - 09/2011
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 08/2018
2	Pathologic Processes 10/2021 - 10/2019
2	Pruritus (Itching) 12/2020 - 01/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 11/2020
2	Pseudohypoaldosteronism 01/2017 - 01/2015
1	Stroke (Strokes) 10/2022
1	Inflammation (Inflammations) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Overactive Urinary Bladder (Overactive Bladder) 01/2022
1	Chronic Cough 01/2022
1	Leukemia 01/2022
1	Intermittent Claudication 12/2020
1	Vomiting 12/2020
1	Abdominal Pain (Pain, Abdominal) 12/2020
1	Nausea 12/2020
1	Thromboangiitis Obliterans (Buerger's Disease) 12/2020
1	Rectal Neoplasms (Rectal Cancer) 08/2020
1	Carcinoma (Carcinomatosis) 10/2019
1	Carcinogenesis 10/2019
1	Hyperhidrosis 10/2019
1	Erythromelalgia (Erythermalgia) 12/2018
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Hyperhomocysteinemia 03/2018
1	Thrombosis (Thrombus) 03/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018
1	Pain (Aches) 01/2018
1	Cholangitis 01/2018
1	Jaundice (Icterus) 01/2018

Drug/Important Bio-Agent (IBA)

7	SaltsIBA 01/2021 - 06/2006
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2010
6	PotassiumIBA 01/2020 - 09/2010
5	ThiazidesIBA 01/2021 - 01/2015
4	SodiumIBA 01/2021 - 06/2006
3	AldosteroneIBA 01/2022 - 02/2012
2	Peptides (Polypeptides)IBA 01/2022 - 06/2006
2	VaccinesIBA 10/2021 - 12/2020
2	CalciumIBA 10/2021 - 05/2014
2	Inactivated VaccinesIBA 10/2021 - 12/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 03/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 11/2009
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020 - 06/2006
2	Epithelial Sodium ChannelsIBA 02/2013 - 06/2006
1	neuromedin UIBA 04/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	CateninsIBA 01/2022
1	5- (5- iodo- 2- isopropyl- 4- methoxyphenoxy)pyrimidine- 2,4- diamineIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	GefapixantIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	ThymopentinIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Purinergic P2X3 ReceptorsIBA 01/2022
1	CationsIBA 01/2022
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Troleandomycin (TAO)FDA Link 12/2020
1	Interleukin-1 (Interleukin 1)IBA 12/2020
1	secukinumabIBA 11/2020
1	Angiotensin IIIBA 01/2020
1	benzamilIBA 01/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	CaveolinsIBA 10/2019
1	AntioxidantsIBA 10/2019
1	CholesterolIBA 10/2019
1	Caveolin 1IBA 10/2019
1	HomoharringtonineIBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Messenger RNA (mRNA)IBA 08/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 03/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2018
1	fibrin fragment D (D-dimer)IBA 03/2018
1	Superoxide DismutaseIBA 01/2018
1	MetallothioneinIBA 01/2018

Therapy/Procedure

3	Sympathectomy (Sympathectomies) 10/2019 - 10/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2018
2	Aftercare (After-Treatment) 12/2020 - 11/2020
2	Self Expandable Metallic Stents 01/2018 - 05/2014
2	Stents 01/2018 - 05/2014
1	Secondary Prevention 10/2022
1	Radiotherapy 01/2022
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 01/2022
1	Surgical Amputation (Amputations) 12/2020
1	Neoadjuvant Therapy 08/2020
1	Therapeutics 10/2019
1	Punctures 10/2019